Next Article in Journal
An Automated Micro-Total Immunoassay System for Measuring Cancer-Associated α2,3-linked Sialyl N-Glycan-Carrying Prostate-Specific Antigen May Improve the Accuracy of Prostate Cancer Diagnosis
Next Article in Special Issue
Detailed Characterization of Sympathetic Chain Ganglia (SChG) Neurons Supplying the Skin of the Porcine Hindlimb
Previous Article in Journal
Heat Shock Factor 1 Depletion Sensitizes A172 Glioblastoma Cells to Temozolomide via Suppression of Cancer Stem Cell-Like Properties
Previous Article in Special Issue
BAG2 Interferes with CHIP-Mediated Ubiquitination of HSP72

Potential Modes of Intercellular α-Synuclein Transmission

Menzies Health Institute Queensland, Griffith University, Gold Coast 4222, Australia
Department of Biomedical Sciences, Faculty of Medical and Health Sciences, Macquarie University, Sydney 2109, Australia
Author to whom correspondence should be addressed.
Academic Editor: Irmgard Tegeder
Int. J. Mol. Sci. 2017, 18(2), 469;
Received: 19 December 2016 / Revised: 1 February 2017 / Accepted: 6 February 2017 / Published: 22 February 2017
(This article belongs to the Special Issue Neuronal Protein Homeostasis in Health and Disease)
Intracellular aggregates of the α-synuclein protein result in cell loss and dysfunction in Parkinson’s disease and atypical Parkinsonism, such as multiple system atrophy and dementia with Lewy bodies. Each of these neurodegenerative conditions, known collectively as α-synucleinopathies, may be characterized by a different suite of molecular triggers that initiate pathogenesis. The mechanisms whereby α-synuclein aggregates mediate cytotoxicity also remain to be fully elucidated. However, recent studies have implicated the cell-to-cell spread of α-synuclein as the major mode of disease propagation between brain regions during disease progression. Here, we review the current evidence for different modes of α-synuclein cellular release, movement and uptake, including exocytosis, exosomes, tunneling nanotubes, glymphatic flow and endocytosis. A more detailed understanding of the major modes by which α-synuclein pathology spreads throughout the brain may provide new targets for therapies that halt the progression of disease. View Full-Text
Keywords: α-synuclein; Parkinson’s disease; multiple system atrophy; dementia with Lewy bodies; exosome; tunneling nanotube; gliosis; glymphatic α-synuclein; Parkinson’s disease; multiple system atrophy; dementia with Lewy bodies; exosome; tunneling nanotube; gliosis; glymphatic
Show Figures

Graphical abstract

MDPI and ACS Style

Valdinocci, D.; Radford, R.A.W.; Siow, S.M.; Chung, R.S.; Pountney, D.L. Potential Modes of Intercellular α-Synuclein Transmission. Int. J. Mol. Sci. 2017, 18, 469.

AMA Style

Valdinocci D, Radford RAW, Siow SM, Chung RS, Pountney DL. Potential Modes of Intercellular α-Synuclein Transmission. International Journal of Molecular Sciences. 2017; 18(2):469.

Chicago/Turabian Style

Valdinocci, Dario, Rowan A.W. Radford, Sue M. Siow, Roger S. Chung, and Dean L. Pountney 2017. "Potential Modes of Intercellular α-Synuclein Transmission" International Journal of Molecular Sciences 18, no. 2: 469.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Back to TopTop